Scopoletin not only has an antidiabetic effect on enhancing PM- GLUT4 expression in 3T3-L1 adipocytes (63) and has been considered as an AMPK activator for insulin signaling regulation (64), but also has effects on gout by inhibiting urate crystal induced inflammation (65). Here, SLC2A4 is linked to gout.